Table 1 Characteristics of obese patients with NAFLD (n 80)
From: Is serum Interleukin-17 associated with early atherosclerosis in obese patients?
Parameter | Mean+/−SD or median plus (25–75 IQR) | Parameter | Mean+/−SD or median plus (25–75 IQR) |
|---|---|---|---|
Age (years) | 46 (34–53) | HDL Females mg/dL | 49.3+/−15 |
Gender M/F | 36/44 | HDL Males mg/dL | 42.7+/−9 |
Obesity Degree I/II/III (n) | 18/26/46 | TG mg/dL | 123.5 (83.5-188) |
BMI | 42.3 (38.1-46.8) | CRP mg/mL | 0.56 (0.27-1.3) |
WC Females (cm) | 118.9+/−12.5 | Fibrinogen g/L | 295.5 (256–357.5) |
WC Males (cm) | 129.3+/−14 | Ferritin Females ng/mL | 41.5 (20–69) |
WHR Females | 0.95 (0.93-0.97 | Ferritin Males ng/mL | 167.5 (85–234) |
WHR Males | 0.98 (0.96-1) | SLD cm | 11.3+/−1.5 |
HS Grade 1/2/3 at US (n) | 22/48/10 | RMR | 2352.2+/−432.7 |
SAT (cm) | 2.6 (2.1-3.1) | Eotaxin pg/mL | 24.6 (6.17-77.5) |
VAT (cm) | 7.5 (6–9.4) | TNF- α pg/mL | 41.8 (8.1-112.7) |
ImTG Score I/II/III/IV at US(n) | 11/23/30/16 | IL-6 pg/mL | 5.7 (2.3-17.5) |
ALT (U/L) | 28 (21.5-29) | IL-8 pg/mL | 23.1 (3.3-68.1) |
CHE (U/L) | 9671.4+/−1882.2 | IFN-γ pg/mL | 158 (56–390) |
AP (U/L) | 73 (61–91) | IP-10 (CXCL10) pg/mL | 405 (255–659) |
γ-GT(U/L) | 25 (16.5-42.5) | MIP-1β (CCL4) pg/mL | 37.2 (24.3-51.9) |
HS grade at US 1/2/3 (n) | 22/50/8 | Fasting insulin μU/mL | 10.9 (7.5-15.8) |
IMT (mm) | 0.09 (0.07-011) | Fasting glucose mg/dL | 96.5 (87–114) |
SBP mm Hg | 130 (120–140) | HOMA | 2.78 (1.85-4.18) |
DBP mm Hg | 80 (80–90) | LDL | 66.8 (33.3-140) |
Smoking status (yes/no) | 42/38 |